Ascentage Pharma (AAPG) Secures Key Drug Listings in China's 2026 NRDL, Expanding Market Access
· gurufocus.com
On November 15, 2026, Ascentage Pharma Group International (AAPG) announced the inclusion of two of its major therapies in China's 2026 National Reimbursement D
On November 15, 2026, Ascentage Pharma Group International AAPG announced the inclusion of two of its major therapies in China’s 2026 National Reimbursement D...